Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iscar in Stage IV NSCLC
NCT00079794Phase 2Completed
- Sponsor
- National Center for Complementary and Integrative Health
- Start
- Sep 2001
- Primary completion
- Feb 2004
- Modality
- PE (Plant Extract)
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of viscum album in non-small cell lung cancer (NSCLC), sponsored by National Center for Complementary and Integrative Health. Primary endpoints: Immune Function and Quality of Life. Started Sep 2001; status: completed.
02
Drugs
viscum album
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00079794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00079794.